Roche(US:RHHBY) 3 6 Ke·2025-12-03 14:14Core Insights - The WISE 2025 Business King Conference, held on November 27-28, is described as an immersive experience rather than a traditional industry summit, focusing on the intersection of technology and business trends [1] - Roche Pharmaceuticals' AI medical product development team presented a talk on "Xiao Luo Zhi Duo Xing," an AI assistant for clinical researchers, which won the "Annual AI Application Scenario Breakthrough Enterprise" award at the conference [1] Summary by Sections Conference Overview - The conference aims to capture real insights from numerous business practices, highlighting trends from AI reshaping hardware boundaries to brand globalization in the context of overseas expansion [1] Presentation by Roche Pharmaceuticals - The presentation by Chen Shuzhan from Roche Pharmaceuticals focuses on the challenges in clinical research and how AI can assist in overcoming these challenges [3][4] - The product "Xiao Luo Zhi Duo Xing" is designed to be a research companion for clinical doctors, addressing pain points in the research process [4] Research Process Challenges - Clinical research is often tedious and requires significant patience, involving multiple stages: topic selection, project initiation, data management, and manuscript writing [6] - The process can take from six months to two years, with potential setbacks if topics are published by others or if proposals require resubmission [6] AI Solution Features - "Xiao Luo Zhi Duo Xing" offers four main functionalities: intelligent topic selection, simulated peer review, literature interpretation, and research proposal writing, which can save users at least 80% of their time compared to traditional methods [7][8] - The intelligent topic selection feature allows users to input keywords and receive valuable research topics based on existing literature, adhering to evidence-based medicine principles [8] - The simulated peer review function mimics feedback from top journals, helping researchers avoid common mistakes before submission [10] User Adoption and Future Outlook - The product has gained over 4,600 users in six months, indicating strong interest from leading hospitals in China [16] - The company envisions a future where AI will simplify research processes, making them more efficient and enjoyable, with aspirations to create a comprehensive AI research assistant [16][17]